During the past decade, Via Libre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Via Libre" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 2 trials, followed by "NGO Via Libre" with 2 trials sponsored, "University of California, Los Angeles" with 2 trials sponsored, "Avexa" with 1 trials sponsored and "Fred Hutchinson Cancer Center" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Via Libre" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Asociacion Civil Via Libre" with 2 trials as a collaborator, "NGO Via Libre" with 2 trials as a collaborator and "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Via Libre" are "HIV Infections" (5 trials), "HIV" (2 trials), "HIV Infection" (2 trials), "Adherence" (1 trials) and "Chlamydia" (1 trials). Many other conditions were trialed in "Via Libre" in a lesser frequency.

Most popular intervention types in "Via Libre" are "Biological" (4 trials), "Behavioral" (3 trials), "Drug" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "2N(t)RTI" (1 trials), "Ad26.COV2.S" (1 trials), "Ad26.Mos4.HIV" (1 trials) and "All licensed antiretroviral medications" (1 trials). Other intervention names were less common.

The vast majority of trials in "Via Libre" are 7 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Via Libre". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Via Libre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Via Libre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".